[25-007851] NIH nhlbi flow cytometry core requires antibodies in order to perform flow cytometry, western blotting, elisa assays, purification of immune cells, QA and QC, and immunophenotyping.
Ended Awarded Last action
- Contract number
- 75N92025F00002
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,000
Award facts
- Contract value 100% obligated
- $17,000.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Franklin Lakes, NJ 07417, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$33 | |
| Original award | $17,033 |
About this award
On April 10, 2025, the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health, awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $17,000.13 to Becton, Dickinson and Company (BD), through its BD Biosciences division. The contract, which carries no small business set-aside designation, will support the NHLBI Flow Cytometry Core facility located in Franklin Lakes, New Jersey. Under this award, BD will supply antibodies and related reagents necessary to enable the Core to conduct flow cytometry analysis, western blotting, enzyme-linked immunosorbent assay (ELISA) testing, immune cell purification, quality assurance and quality control activities, and immunophenotyping studies. The contract is scheduled for ultimate completion by June 10, 2025.
This BPA call is structured as a child order under a larger Blanket Purchase Agreement vehicle established between NIH and BD, reflecting the government's reliance on BD's established capabilities in flow cytometry technologies and related biomedical research consumables. BD, a global medical technology manufacturer specializing in flow cytometry instruments, cell imaging systems, and laboratory reagents, holds multiple indefinite delivery contracts with federal agencies including the Department of Veterans Affairs and various NIH components. The award demonstrates the NHLBI's streamlined procurement approach for critical research consumables through existing contract mechanisms, enabling efficient access to specialized antibodies and reagents essential to the Core's research support mission.
Quick answers
Who was awarded contract 75N92025F00002?
75N92025F00002 was awarded to Becton, Dickinson And Company by National Heart Lung and Blood Institute (National Institutes of Health) on April 10, 2025.
How much is contract 75N92025F00002 worth?
The government has obligated $17,000 on 75N92025F00002.
Is contract 75N92025F00002 an order under another contract?
Yes. 75N92025F00002 is a BPA call under 75N98024A00047, a blanket purchase agreement.
Was contract 75N92025F00002 competed?
The extent of competition for 75N92025F00002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award